Artificial intelligence also energizes natural medicine
Artificial intelligence can analyze billions of combinations between plants or molecules. What speed up the composition of active mixtures by limiting side effects.
A revolution for veterinary dermatology
Rhubarb, queen of the meadows, vesicular fucus, Valerian, business, mountain savory, tea, cloves, arbutus, sweet fennel, vine, kinkélibali, lemony verbena, great chamomile, rosemary, juniper ...
The patented composition of the effiskin veterinary range, launched in 2020, seems at first glance to be more of the grandmother's remedy than a serious dermatological approach.
And yet, to achieve this result, they are near 1 billion combinations which were envisaged and analyzed by an artificial intelligence algorithm.
Dedicated to Treatment of skin with pyodermal tendency in dogs, the product Synherbs 16.5 has been the subject of extremely pushed in the laboratory, directly on bacteria responsible for the infection.
By combining Machine learning and experiences in vitro, a unique 16 plant combination is identified and incorporated into the formulas to quickly relieve itching in dogs.
Here's how it works:
Step 1
A 1st mixture of plants is randomly made from a database of 1000+ medicinal plants, selected for their safety.
2nd step
The mixture is tested in the laboratory and the results analyzed by a computer that offers us a new mixture of plants to be tested. This is called Machine Learning.
Step 3
By successive cycles of tests, analyzes and experiences, AI manages to refine research until you obtain maximum efficiency.
A 100% French innovation
"In a few months, we reach a proposal that would take several hundred, even thousands of years, in a traditional way. We could even accelerate the process and imagine finding a parade in 24 to 36 hours in the event of a bacteriological terrorist attack. "
Behind this innovation, we find the French startup Alphanosos, including the founder, Doctor Pascal Mayer, was awarded in 2022 the prestigious Breakthrough Prize in the Living Sciences category.
At Glaxosmithkline in Plan-les Ouates (GE) at the time of the redemption of the Geneva laboratory by Serono in 1997, he was one of the pioneers of massively parallel sequencing technologies of the genome through the predictive Medicine spin-off.
With alphanosos, he developed an algorithm to compose mixtures from a collection of edible plants with water extraction, without chemical solvent. "We work a lot on the antimicrobial. We are going to seek an association which eliminates, for example, the golden staphylococcus while not attacking good bacteria. "
Fewer side effects
The peculiarity of Effiskin has certain advantages according to Doctor Gerardo Turcatti: “Instead of isolating a unique active molecule as in classic pharmaceutical research, we are trying to find on mixtures of plants synergetic positive effects while reducing the effects potential negatives thanks to the decrease in concentrations of each active ingredient present in these mixtures. We work exclusively with edible plants, mostly organic farming, in order to limit the toxicity of the product as much as possible. This unique approach makes it possible to develop effective formulas, without the undesirable effects of traditional treatments. "Effiskin has no toxicity in the event of licking and its manufacture is non-polluting (without chemical solvent).
"We work exclusively with edible plants, mostly organic farming, in order to Limit the toxicity of the product as much as possible. This unique approach makes it possible to develop effective formulas, without the undesirable effects of traditional treatments. "
Effiskin does not present No toxicity in case of licking And its manufacture is non-polluting (without chemical solvent).